OOIR: Observatory of International Research

Papers

(The TQCC of Expert Review of Proteomics is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
The path to anti-vector vaccines: current advances and limitations in proteomics and bioinformatics	80
How can proteomics help solve the lack of biomarkers to aid in the early diagnosis of motor neuron disease (MND)?	55
Proteomic insights into the extracellular matrix: a focus on proteoforms and their implications in health and disease	38
Proteomic profiling and network biology of colorectal cancer liver metastasis	22
24th Human Proteome Organization World Congress; Results from the Early Career Researcher Manuscript Competition announcement	19
Oncoproteomic profiling of AML: moving beyond genomics	18
Cutaneous leishmaniasis: multiomics approaches to unravel the role of immune cells checkpoints	18
The interdependence of machine learning and LC-MS approaches for an unbiased understanding of the cellular immunopeptidome	17
Omics and rare diseases: challenges, applications, and future perspectives	16
Mapping the human brain proteome: opportunities, challenges, and clinical potential	16
The method developer’s guide to oligonucleotide design	14
Positional proteomics: is the technology ready to study clinical cohorts?	13
LC-MS/MS: A sensitive and selective analytical technique to detect COVID-19 protein biomarkers in the early disease stage	11
Advancing kidney transplant outcomes: the role of urinary proteomics in graft function monitoring and rejection detection	10
A computational method for the prediction and functional analysis of potential Mycobacterium tuberculosis adhesin-related proteins	10
Utilizing databases for astrocyte secretome research	10
Proteomic tools to study phosphorylation of intrinsically disordered proteins	10
Optimization of glycopeptide enrichment techniques for the identification of clinical biomarkers	9
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology	8
Proteogenomic profiling of acute myeloid leukemia to identify therapeutic targets	8
Proteomic profiling of cerebrospinal fluid reveals pathophysiology changes and diversity of treatment response in pediatric Streptococcus pneumoniae meningitis	8
Role of structural disorder in the multi-functionality of flavivirus proteins	7
Unravelling disease complexity: integrative analysis of multi-omic data in clinical research	7
Recent advances in mass spectrometry for the detection of doping	7
Integrated metabolomics and proteomics analysis of plasma lipid metabolism in Parkinson’s disease	6

Proteomic interrogation of the human olfactory system: the road ahead	6
Mass spectrometry (MS)-based proteomics and the sulfome: clinical potential	6
Rebellion of the deregulated regulators: What is the clinical relevance of studying intrinsically disordered proteins?	6
T cell population size control by coronin 1 uncovered: from a spot identified by two-dimensional gel electrophoresis to quantitative proteomics	6
How to maximize power for differential expression analysis in discovery omics through experimental design	6
Analyzing the glial proteome in Alzheimer’s disease	6
A Galaxy of informatics resources for MS-based proteomics	6
Advances in the clinical use of metaproteomics	5
Revisiting the antigen markers of vector-borne parasitic diseases identified by immunomics: identification and application to disease control	5
Tackling reproducibility: lessons for the proteomics community	5
The use of urine peptidomics to define dietary gluten peptides from patients with celiac disease and the clinical relevance	5
The evolution of analytical techniques for multiplex analysis of protein biomarkers	5
How glycomic studies can impact on prostate cancer	5
Glycosylation in cancer as a source of biomarkers	5
Extracellular vesicle proteomics in brain solid tumors: future strategy for personalized medicine	5
Salivary metabolomics in early detection of oral squamous cell carcinoma – a meta-analysis	5
Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategies	5